drugset / Trial / NCT04698330

Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA

NCT04698330

Phase 4 Not yet recruiting 240 enrolled Second Xiangya Hospital of Central South University
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose of this study is to evaluate the effects of oral berberine (BBR) and inulin combined with insulin therapy on diabetes care in patients with LADA.

Timeline

Start
2022-05
Primary completion
2025-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Berberine Traditional medicine (herbal / TCM) 0.6 g Oral
Subject Inulin Other / unclassified 0.6 g Oral